Static and repeated accommodation both significantly reduce IOP

Article

Both static and repeated accommodation significantly reduce intraocular pressure (IOP).

Both static and repeated accommodation significantly reduce intraocular pressure (IOP), reveals a paper in the Journal of Glaucoma.

Dr Frank Jenssen et al., Department of Ophthalmology, Haukeland University Hospital, Bergen, Norway, included 33 healthy participants aged 20 to 29 years in a randomized, single-blind study.

After viewing a target in the distance for 10 minutes baseline IOP was measured. Participants focused on a near target for three minutes to achieve static accommodation. Volunteers were also asked to alternate their focus on near and distant targets for three minutes to achieve repeated accommodation.

An infrared photoreceptor was used to continuously monitor accommodative responses and Goldmann tonometry was conducted straight after the accommodative process.

After static accommodation IOP was 13.4±2.4 mmHg and for repeated accommodation it was 12.7±2.3 mmHg. This demonstrated a mean change in IOP of −1.76±1.17 mmHg and −2.06±1.48 mmHg, for static and repeated accommodation respectively. Although the drop was greater in repeated accommodation than static, the difference was not statistically significant.

The investigation suggests that aqueous humour outflow isn't strongly influenced by recurrent ciliary muscle contractions.

Recent Videos
Patrick C. Staropoli, MD, discusses clinical characterisation of Hexokinase 1 (HK1) mutations causing autosomal dominant pericentral retinitis pigmentosa
Richard B. Rosen, MD, discusses his ASRS presentation on illuminating subclinical sickle cell activities using dynamic OCT angiography
ASRS 2024: Socioeconomic barriers and visual outcomes in patients with rhegmatogenous retinal detachments, from Sally S. Ong, MD
Ashkan Abbey, MD, speaks about his presentation on the the CALM registry study, the 36-month outcomes of real world patients receiving fluocinolone acetonide 0.18 mg at the annual ASRS meeting in Stockholm, Sweden.
Nikoloz Labauri, MD, FVRS, speaks at the 2024 ASRS meeting about suspensory macular buckling as a novel technique for addressing myopic traction maculopathy
Jordana Fein, MD, MS, speaks with Modern Retina about the IOP outcomes with aflibercept 8 mg and 2 mg in patients with DME through week 48 of the phase 2/3 PHOTON trial at the annual ASRS meeting in Stockholm, Sweden.
John T. Thompson, MD, discusses his presentation at ASRS, Long-Term Results of Macular Hole Surgery With Long-Acting Gas Tamponade and Internal Limiting Membrane Peeling
ASRS 2024: Michael Singer, MD, shares 100-week results from the RESTORE trial
© 2024 MJH Life Sciences

All rights reserved.